TerrAscend (OTCMKTS:TSNDF – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01), Zacks reports. TerrAscend had a negative return on equity of 32.93% and a negative net margin of 31.01%.
TerrAscend Trading Down 5.6%
TSNDF stock traded down $0.03 during mid-day trading on Thursday, hitting $0.47. 421,720 shares of the company were exchanged, compared to its average volume of 312,282. TerrAscend has a 12-month low of $0.35 and a 12-month high of $1.45. The firm has a market capitalization of $143.77 million, a P/E ratio of -4.23 and a beta of 1.47. The business has a fifty day simple moving average of $0.57 and a 200-day simple moving average of $0.63. The company has a quick ratio of 1.20, a current ratio of 1.83 and a debt-to-equity ratio of 2.37.
About TerrAscend
TerrAscend Corp. is a North American cannabis company that cultivates, processes, manufactures and sells cannabis products through a combination of wholesale and retail operations. Its product portfolio includes flower, pre-rolls, concentrates, vape products, edibles, tinctures, topicals and other cannabis-derived products.
The company serves medical and adult-use cannabis markets in several U.S. states, including Pennsylvania, New Jersey, Maryland, Michigan, Ohio and California, as well as the Canadian market.
Read More
- Five stocks we like better than TerrAscend
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
